CovalX and the Swiss Federal Institute of Technologie (IMSB, Prof. Ruedi Aebersold) started a research project focus on the development of new methodology for the characterization of monoclonal antibody epitopes. The research project is supported by the Swiss Commission of Technology and Innovation (KTI) and CovalX.